Why Increased Diversity in Dermatologic Clinical Trials Is Not Inherently Ethical-An Evidence-Based, Community-Engaged Approach to Diverse Trial Recruitment
JAMA Dermatol
.
2022 Oct 1;158(10):1219.
doi: 10.1001/jamadermatol.2022.3109.
Authors
Emmanuella Ngozi Asabor
1
2
3
,
Jeffrey M Cohen
4
,
Jaya Aysola
3
5
6
Affiliations
1
Yale School of Medicine, New Haven, Connecticut.
2
Department of Epidemiology, Yale School of Public Health, New Haven, Connecticut.
3
Penn Medicine Center for Health Equity Advancement, University of Pennsylvania Health System, Philadelphia.
4
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
5
Office of Inclusion, Diversity, and Equity , Perelman School of Medicine, University of Pennsylvania, Philadelphia.
6
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
PMID:
35976641
DOI:
10.1001/jamadermatol.2022.3109
No abstract available
Publication types
Comment
MeSH terms
Community Participation*
Health Knowledge, Attitudes, Practice
Humans
Patient Selection
Stakeholder Participation*